CA1040658A - INDUSTRIAL METHOD FOR PRODUCING .alpha.1-TERT.-BUTYLAMINO-METHYL-4-HYDROXY-M-XYLENE-.alpha.1,.alpha.3-DIOLE - Google Patents
INDUSTRIAL METHOD FOR PRODUCING .alpha.1-TERT.-BUTYLAMINO-METHYL-4-HYDROXY-M-XYLENE-.alpha.1,.alpha.3-DIOLEInfo
- Publication number
- CA1040658A CA1040658A CA223,245A CA223245A CA1040658A CA 1040658 A CA1040658 A CA 1040658A CA 223245 A CA223245 A CA 223245A CA 1040658 A CA1040658 A CA 1040658A
- Authority
- CA
- Canada
- Prior art keywords
- alpha
- tert
- xylene
- diole
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title abstract description 4
- 238000000034 method Methods 0.000 claims abstract description 14
- 150000001875 compounds Chemical class 0.000 claims abstract description 12
- 150000002466 imines Chemical class 0.000 claims abstract description 12
- 238000005984 hydrogenation reaction Methods 0.000 claims abstract description 9
- 239000002253 acid Substances 0.000 claims abstract description 5
- 125000005002 aryl methyl group Chemical group 0.000 claims abstract description 5
- 150000003839 salts Chemical class 0.000 claims abstract description 5
- 125000006239 protecting group Chemical group 0.000 claims abstract description 4
- 239000004215 Carbon black (E152) Substances 0.000 claims abstract description 3
- 125000003118 aryl group Chemical group 0.000 claims abstract description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 3
- 229930195733 hydrocarbon Natural products 0.000 claims abstract description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 21
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 17
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 16
- 239000003054 catalyst Substances 0.000 claims description 5
- 239000012419 sodium bis(2-methoxyethoxy)aluminum hydride Substances 0.000 claims description 4
- JEDZLBFUGJTJGQ-UHFFFAOYSA-N [Na].COCCO[AlH]OCCOC Chemical compound [Na].COCCO[AlH]OCCOC JEDZLBFUGJTJGQ-UHFFFAOYSA-N 0.000 claims description 3
- 238000009903 catalytic hydrogenation reaction Methods 0.000 claims 1
- 150000007522 mineralic acids Chemical class 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 230000003197 catalytic effect Effects 0.000 abstract description 3
- 238000010924 continuous production Methods 0.000 abstract description 3
- 230000036571 hydration Effects 0.000 abstract description 3
- 238000006703 hydration reaction Methods 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract description 3
- 239000013067 intermediate product Substances 0.000 abstract description 2
- 238000007792 addition Methods 0.000 description 21
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 description 20
- 239000011541 reaction mixture Substances 0.000 description 18
- 238000009835 boiling Methods 0.000 description 13
- 238000001704 evaporation Methods 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 10
- 230000008020 evaporation Effects 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- 229910052711 selenium Inorganic materials 0.000 description 9
- 239000011669 selenium Substances 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical class O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000002844 melting Methods 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 238000013019 agitation Methods 0.000 description 5
- 239000003638 chemical reducing agent Substances 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 125000004494 ethyl ester group Chemical group 0.000 description 4
- -1 hydrocarbon radical Chemical class 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 239000004411 aluminium Substances 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910000091 aluminium hydride Inorganic materials 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- IOHPVZBSOKLVMN-UHFFFAOYSA-N 2-(2-phenylethyl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1CCC1=CC=CC=C1 IOHPVZBSOKLVMN-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- RGNAFCUVZPWLLZ-UHFFFAOYSA-N 1,5-dimethylcyclohexa-2,4-diene-1-carbaldehyde Chemical compound C1(CC(=CC=C1)C)(C)C=O RGNAFCUVZPWLLZ-UHFFFAOYSA-N 0.000 description 1
- NXXYKOUNUYWIHA-UHFFFAOYSA-N 2,6-Dimethylphenol Chemical compound CC1=CC=CC(C)=C1O NXXYKOUNUYWIHA-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- 208000009079 Bronchial Spasm Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- 208000005279 Status Asthmaticus Diseases 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- ZYBWTEQKHIADDQ-UHFFFAOYSA-N ethanol;methanol Chemical compound OC.CCO ZYBWTEQKHIADDQ-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229940015043 glyoxal Drugs 0.000 description 1
- 235000013847 iso-butane Nutrition 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000003613 toluenes Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/56—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups
- C07C215/58—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
- C07C215/60—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain the chain having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
ABSTRACT OF THE DISCLOSURE
The present invention relates to a method for producing therapeutically valuable .alpha.2-tert.-butylaminomethyl-4-hydroxy-m-xylene-.alpha.2 ,.alpha.3-diole, which has the formula and its acid addition salts, characterized in that an imine deri-vative having the formula where R stands for a lower straight-chain or branched hydrocarbon radical containing 1 to 6 carbon atoms, and Ar stands for an aryl group, is converted by simultaneous hydrogenation and reduction into a compound having the formula
The present invention relates to a method for producing therapeutically valuable .alpha.2-tert.-butylaminomethyl-4-hydroxy-m-xylene-.alpha.2 ,.alpha.3-diole, which has the formula and its acid addition salts, characterized in that an imine deri-vative having the formula where R stands for a lower straight-chain or branched hydrocarbon radical containing 1 to 6 carbon atoms, and Ar stands for an aryl group, is converted by simultaneous hydrogenation and reduction into a compound having the formula
Description
New industrial method for producing~ -tert-butyl-aminomethyl-4-hydroxy-m-xylene-~l, ~3-diole The present invention concerns a new method for producing therapeutically valuable ~l-tert-butylaminomethyl-4-hydroxy-m-xylene-~l, ~3-diole, which has the formula \ OH
; HO ~ C~CH~HC(CH3)3 and its acid addition salts.
The compound is known for its pharmacological properties and it has come into extensive use in treating status asthmaticus and other forms of severe bronchospasm.
The preparing of ~l-tert.-butylaminomethyl-4-, hydroxy-m-xylene-~l,~3-diole has been described e.g. in the ~ British Patents N. 1,200,~386 and 1,247,370. The method of the `! British Patent N. l, 200,886 involves several intermediate , . ~
, steps. In addition, the reduction of ester group is carried out with lithium aluminium hydride in diethyl ether or tetra-~ 20 hydrofurane, which is an expensive step and one that is I dangerous when performed on an industrial scale, owing to the risk of ignition of the solvents. The British Patent N
l,247,370 likewise comprises several steps, and part of the intermediates are produced with a very poor yield. In this method the generally known selenium dioxide oxidation is employed. The present invention also incorporates a similar oxidation, but the starting substance is another compound.
The method of the British Patent N 1,247,370 comprises as its last step a procedure which is unsuitable for industrial production runs: lithium aluminium hydride reduction and extraction of the product from an aqueous solution. However, knowing the solubility characteristics of ~ -tert.-butylamino-.' ~
., .
.. . .
~ 104~;S~
methy,l-4-hydroxy-m-xylene-al, ~3-diole, one may say that the method is realizable on a laboratory scale only.
A method appropriate for industrial production work has now been invented, wherein ~ -tert.-butylaminomethyl-4-hydroxy-m-xylene-a1,a3-diole can be easily produced with a good yield in a continuous process, without isolating the intermediate products. The invention is characterized by a continuous production process taking place in one substrate and starting from a benzoic acid derivative having the formula ROOC
ArCH20~ COCH3 II
wherein R = a lower straight-chain or branching hydrocarbon radical containing from 1 to 6 carbon atoms, and Ar = an aryl group, and which is oxidized with selenium dioxide in dioxane ,~
to give the corresponding glyoxal derivative, which has the formula .1 .
, ROOC
. '~ . ' ' :
; ArCH20 ~ COCHO III ~; -.`
~, and which is reacted with tert.-butylamine, which has the -`' formula ! H2NC(CH3)3 IV
:~ ~
to give an imine derivative having the formula ~rCH20 - ~ CCH=NC(CH3~3 and which latter is converted by simultaneous hydrogenation and reduction with an alkali metal aluminium hydride deriva-. , .
104065~3 tive,selected from the group consisting of sodium bis(2-methoxyethoxy)aluminium hydride of the formula NaAl(OCH2CH2OCH3)2H2 VI
and sodium aluminium diethylhydride of the formula ~aA~C2H5)2 2 VII
to give a compound having the formula ~2 \f~ OH
ArCH2O ~ _ CHcH2NHc(cH3)3 VIII
-'' and from which latter the arylmethyl protective group may~ -be removed by catalytic hydration.
An essential feature of the invention is the continui-ty of the method, which has been achieved by protecting the phenolic hydroxyl group in the benzoic acid derivative with the aid of a suitable arylmethyl group. In this manner the losses in the isolation and purification of intermediates are avoided and the final product is obtained in a highly pure and easily isolated form. The intermediates (III, V
and VIII) formed in our method all are also new compounds, the preparation and properties of which have not been described in the literature heretofore.
In our method the ester derivative (II) is first oxidized with selenium dioxide in dioxane, preferably at the 1, boiling point of the solvent, to give the corresponding glyoxal s derivative (III). In the continuation the reaction mixture may be used as such, after the selenium precipitated in the reaction has been filtered off.
When to the filtrate tert.- butylamine is added, standing at room temperature for a few hours already suffices for the formation of the desired imine derivative (V). Thus, by means of a suitable choice of solvent and of temperature, ~ .
. ~, .
1()406S8 the reaction of the tert.-butylamine with the second reactive keto group in the glyoxal derivative (III) has been prevented.
An unexpected feature of the invention is further-more the simultaneous hydrogenation and reduction of the carbon-nitrogen double bond in the imine derivative (V) and of the keto and ester group by the aid of a suitable alkali metal aluminium hydride derivative. No reaction of this type has been presented in the literature heretofore. When the reducing ~ -agent used is sodium bis(2-methoxyethoxy)-aluminium hydride or sodium aluminium diethylhydride, the solvent is most usually benzene or toluene, which both may also be used in the present instance. However, it has unexpectedly been found that a better result is achieved if the reaction is carried out in dioxane that is, the reaction mixture used in the preparation of the imine derivative may be used as such. It is indicated to evaporate the excess amount of tert.-butylamine at reduced pressure, in order to save reducing agent. This simultaneous -hydrogenation and reduction of the imine derivative (V) is only possible provided that the phenolic hydroxyl group in the benzene ring is protected. If no protection has been applied, one has to extract the product from an aqueous solu-tion, considering the known solubility characteristics of ~1_ ' tert.-butylaminonethyl-4-hydroxy-m-xylene-~1, ~3-diole, thisis an impossible undertaking on an industrial scale, and in ; addition considerable amounts of undesired secondary products are formed.
The arylmethyl protective group in the compound (VIII) may be removed by catalytic hydration, for which ' palladium carbon, for instance, is a suitable catalyst and '~ 30 alcohol, for instance, is a suitable solvent.
The invention is illustrated with the ald of examples in the following.
.
- . - . ~. , ., ~ . , : : , Example 1 1040~58 -tert.-butylaminomethvl-4-benzyloxy-m-xylene-~1, a3-diole To 59 kg of dioxane, 0.35 kg water are added and the mixture is heated to 70-80C. Addition of 4.39 kg selenium dioxide. After the selenium dioxide has dissolved, 11.8 kg ethylester of 5-aceto-2-benzyloxybenzoic acid, dissolved in 35.5 kg dioxane, are added. The reaction mixture is further heated during this addition until the reaction mixture boils (appr. 100 C). Reflux boiling is continued for 6 hrs. During the boiling the colour bf the reaction mixture turns black, owing to the selenium precipitated.
After the boiling the mixture is allowed to cool to room temperature. The selenium is filtered off. (If it is desired --to isolate the glyoxal derivative, this is done by evaporating the dioxane, whereby the glyoxal derivative, prepared in this manner, is obtained as a viscous oil.) Addition to the filtrate at room temperature, of 5.9 kg tert.-butylamine and agitation for 4 hrs at room temperature. Evaporation of the excess of tert.-butylamine at reduced pressure.
The reaction mixture is poured, in a nitrogen atmosphere, into 40 kg of a 70% benzene solution of sodium bis(2-methoxyethoxy~aluminium hydride. The addition is made at about 60C. After the addition, reflux boiling for one hour. The complex compound of reducing agent and product is decomposed in normal manner with the aid of water and hydrochloric acid. The oily product layer is separated, ~ dissolved in chloroform, dried with sodium sulphate and treated ; with active carbon. Evaporation of the chloroform at reduced pressure. From the evaporation residue the product may be recrystallized from ethanol if necessary. Yield: 8.8-9~0 kg (65-70% of theoretical), melting point: appr.l35C.
:' :
., ,,,, , . . ,. ., . ~ : . .
,: ,. .:... : . ' ., .' , , :
Example 2 104~6S8 Start as in Example 1, but after preparation of the imine derivative the solvents are evaporated. By this procedure the imine derivative is obtained as a viscous oil, which is dissolved in 80 kg benzene. The benzene solution is poured, in a nitrogen atmosphere, into 40 kg of a 70% benzene solution of sodium bis(2-methoxyethoxy) aluminium hydride. Continue as in Example 1. Yield: 7.5-8.0 kg (58-62% of theoretical), melting point: appr. 135C. -Example 3 As Examples 1 and 2, but using instead of the ethyl ester of 5-aceto-2-benzyloxybenzoic acid, the equivalent amount of methylester. ~ ~
Example 4 ~ -To 66 kg of dioxane, 0.4 kg water are added and the mixture is heated to 70-80C. Addition of 4.92 kg selenium -~
dioxide. After the selenium dioxide has dissolved, addition of 13.2 kg ethylester of 5-aceto-2-benzyloxybenzoic acid, dissolved in 40 kg of dioxane. Heating continued until the '~ 20 reaction mixture boils (appr. 100C), followed by reflux boiling for 6 hrs. During the boiling the reaction mixture turns black - from the selenium precipitated. The reaction mixture is allowed to cool to room temperature and the precipitated selenium is filtered off. Addition to the filtrate at room temperature, of 6.6 kg tert.- butylamine and agitation at room temperature for 4 hrs. Evaporation of the excess of tert.-butylamine at reduced pressure.
; Dioxane solution at room temperature is added, in a nitrogen atmosphere, to 85.5 kg of 25% toluene solution of sodium aluminium diethyldihydride at a rate such that the temperature in the reaction mixture does not surpass 25C.
After this addition, continue agitating at 25C for one hour.
,, . : . . . , . . : ~ ,.
.: , : . . .
.
The complex compound o~ product and reducing agent thus formed is decomposed in normal manner by additing water and alkali solution. The additions have to be made slowly, owing to the effervescence caused by the liberated ethane.
The organic phase is separated and inspissated. From the evaporation residue the product may be recrystallized from ethanol if required. Yield: 9.5-10.3 kg (65-70% of theore-tical), melting point: appr. 135C.
Example 5 As Example 4, but after preparation of the imine derivative the solvents are evaporated. The imine derivative is then obtained as a viscous oil, which is dissol~ed in 90 kg of toluene, and this toluene solution is used in the continua-tion. Continue as in Example 4. Yield: 8.5-9.1 kg (58-62%
of theoretical), melting point: appr. 135C.
Example 6 As Examples 4 and 5, but instead of the ethylester of 5-aceto-2-benzyloxybenzoic acid, use the equivalent amount of methylester.
Example 7 a1-tert -butylaminomethyl-4-hydroxy-m-xylene-al, a3-diole 10 kg of al-tert. -butylaminomethyl-4-benzyloxy-~ m-xylene-al, a3 diole are added to 135 kg of 95% ethanol.
-' Addition of 0.3 kg palladium carbon and hydrogenation at normal pressure, until the hydrogen consumption ceases. After , removal of the catalyst, evaporate the solvents. From the , evaporation residue the product is crystallized with the aid of a methanol-ethanol mixture. Yield: 6.5 kg (90% of theoretical?, melting point: 157-158C.
Example 8 a1=tert.-butylaminomethyl-4-hvdroxY-m-xylene-al,~3-diol To 66 kg of dioxane, 0.4 kg water are added and the mixture is heated to 70-80C. 4.92 kg of selenium dioxide are ~ 7 ~
: , :
., ., . , ., .. . , ,, .
1~40658 added. On dissolution of the selenium dioxide, 13.2 kg of 5-aceto-2-benzyloxybenzoic acid ethyl ester, solved in 40 kg of dioxane, are added. Heating is continued until the reaction mixture boils (appr. 100C), followed by reflux boiling for six hours. During the boiling the reaction mixture turns black from precipitated selenium. The reaction mixture is ~ -allowed to cool to room temperature and the precipitated selenium is filtered off. Addition to the filtrate at room temperature of 6.6 kg tert. butylamine and agitation at room ~-temperature during four hours. The excess tert. butylamine -~
is evaporated at reduced pressure.
Dioxane solution at room temperature is added in a nitrogen atmosphere to 85.5 kg of a 25% toluene solution of sodium aIuminium diethyldihydride at a rate such that the temperature in the reaction mixture does not exceed 25C.
Following the addition, agitation is continued at 25C for one hour. The complex compound of product and reducing agent that has formed is decomposed in normal manner by adding water and alkali solution. The additions have to be made slowly owing to the effervescence caused by released ethane.
The organic phase is separated and insipissated. 135 kg of 95% ethanol are added to the inspissation residue. Further, addition of 0.3 kg of 10% palladium carbon and hydrogenation at normal pressure, until the hydrogen consumption ceases. On removal of the catalyst, the solvents are evaporated. The product is crystallized from the evaporation residue with the aid of a methanol/ethyl acetate mixture.
The yield is 6.2-6.7 kg (59-63% of theoretical), -melting point 157-158C.
Example 9 ~ ;
-tert.-butylaminomethy1-4-hydroxv-m-xylene-~1, ~3-diol To 59 kg of dioxane, 0,35 kg water are added and k ~ .
`' ... , . : : .
,: ~ , . . , ; :
lQ4~658 the mixture is heated to 70-80C. 4.39 kg of selenium dioxide are added. On dissolution of the selenium dioxide, 11.8 kg of 5-aceto-2-benzyloxybenzoic acid ethyl ester, solved in 35.5 kg of dioxane, are added. The reaction mixture is further heated during the addition until the reaction mixture boils (appr. 100C). Reflux boiling is continued for six hours.
I During the boiling the colour of the reaction mixture turns j black, owing to precipitated.
, .
A
,~ ' ' . . .
104al~S~
selenium. ~fter boiling, the mixture i9 allowed to cool to room temperature. The selenium is filtered off (If it is de 9i-red to isolate the glyoxal derivative, this is done by evapora-ting the dioxane, whereby the glyoxal derivative, prepared in this manner~ is obtained as a viscous oil.) To the filtrate at room temperature, 5.9 kg of tert.butyla-mine are added, with agitation at room temperature during four hours. Evaporation of the exce~s tert.butylamine at reduced pressure.
The reaction mixture is made to run, in a nitrogen atmosph~-re, into 40 kg of 70% benzene solution of sodium bis(2-methoxy) aluminiumhydride. The addition is made at appr. 60C. After ; this addition, reflu~ boiling for one hour. The complez com-pound which is formed between the reducing agent and the pro-i duct i9 decomposed in normal manner with the aid of water and hydrochloric acid. The oily product layer is separated, solved 1 in chloroform, set free from it~ hydrochloride salt with a basic I ~olution, dried with sodium sulphate and treated with active carbon. ~he chloroform is evaporated at reduced pressure. To the evaporation residue 120kg of 95% ethanol are added. Addi-tion of 0.26 kg of 10~ palladium carbon and hydrogenation at normal pressure, until the hydrogen consump-tion ceases. After , removal o~ the catalyst, the solvents are evaporated. ~he pro-. .
duct is crystallized from the evaporation residue with the aid of a methanol/ethyl aoetate mixture.
The yield is 5.5-5.9 kg (58-62% of theoretical), melting ~ -point 157-158C.
.
~; ~ . . - , .
.''i.................................................... . .
:, .
_ ~ _ :~
.~. . . . . ..
. .
. . ... . . , . . :: . . , :
; HO ~ C~CH~HC(CH3)3 and its acid addition salts.
The compound is known for its pharmacological properties and it has come into extensive use in treating status asthmaticus and other forms of severe bronchospasm.
The preparing of ~l-tert.-butylaminomethyl-4-, hydroxy-m-xylene-~l,~3-diole has been described e.g. in the ~ British Patents N. 1,200,~386 and 1,247,370. The method of the `! British Patent N. l, 200,886 involves several intermediate , . ~
, steps. In addition, the reduction of ester group is carried out with lithium aluminium hydride in diethyl ether or tetra-~ 20 hydrofurane, which is an expensive step and one that is I dangerous when performed on an industrial scale, owing to the risk of ignition of the solvents. The British Patent N
l,247,370 likewise comprises several steps, and part of the intermediates are produced with a very poor yield. In this method the generally known selenium dioxide oxidation is employed. The present invention also incorporates a similar oxidation, but the starting substance is another compound.
The method of the British Patent N 1,247,370 comprises as its last step a procedure which is unsuitable for industrial production runs: lithium aluminium hydride reduction and extraction of the product from an aqueous solution. However, knowing the solubility characteristics of ~ -tert.-butylamino-.' ~
., .
.. . .
~ 104~;S~
methy,l-4-hydroxy-m-xylene-al, ~3-diole, one may say that the method is realizable on a laboratory scale only.
A method appropriate for industrial production work has now been invented, wherein ~ -tert.-butylaminomethyl-4-hydroxy-m-xylene-a1,a3-diole can be easily produced with a good yield in a continuous process, without isolating the intermediate products. The invention is characterized by a continuous production process taking place in one substrate and starting from a benzoic acid derivative having the formula ROOC
ArCH20~ COCH3 II
wherein R = a lower straight-chain or branching hydrocarbon radical containing from 1 to 6 carbon atoms, and Ar = an aryl group, and which is oxidized with selenium dioxide in dioxane ,~
to give the corresponding glyoxal derivative, which has the formula .1 .
, ROOC
. '~ . ' ' :
; ArCH20 ~ COCHO III ~; -.`
~, and which is reacted with tert.-butylamine, which has the -`' formula ! H2NC(CH3)3 IV
:~ ~
to give an imine derivative having the formula ~rCH20 - ~ CCH=NC(CH3~3 and which latter is converted by simultaneous hydrogenation and reduction with an alkali metal aluminium hydride deriva-. , .
104065~3 tive,selected from the group consisting of sodium bis(2-methoxyethoxy)aluminium hydride of the formula NaAl(OCH2CH2OCH3)2H2 VI
and sodium aluminium diethylhydride of the formula ~aA~C2H5)2 2 VII
to give a compound having the formula ~2 \f~ OH
ArCH2O ~ _ CHcH2NHc(cH3)3 VIII
-'' and from which latter the arylmethyl protective group may~ -be removed by catalytic hydration.
An essential feature of the invention is the continui-ty of the method, which has been achieved by protecting the phenolic hydroxyl group in the benzoic acid derivative with the aid of a suitable arylmethyl group. In this manner the losses in the isolation and purification of intermediates are avoided and the final product is obtained in a highly pure and easily isolated form. The intermediates (III, V
and VIII) formed in our method all are also new compounds, the preparation and properties of which have not been described in the literature heretofore.
In our method the ester derivative (II) is first oxidized with selenium dioxide in dioxane, preferably at the 1, boiling point of the solvent, to give the corresponding glyoxal s derivative (III). In the continuation the reaction mixture may be used as such, after the selenium precipitated in the reaction has been filtered off.
When to the filtrate tert.- butylamine is added, standing at room temperature for a few hours already suffices for the formation of the desired imine derivative (V). Thus, by means of a suitable choice of solvent and of temperature, ~ .
. ~, .
1()406S8 the reaction of the tert.-butylamine with the second reactive keto group in the glyoxal derivative (III) has been prevented.
An unexpected feature of the invention is further-more the simultaneous hydrogenation and reduction of the carbon-nitrogen double bond in the imine derivative (V) and of the keto and ester group by the aid of a suitable alkali metal aluminium hydride derivative. No reaction of this type has been presented in the literature heretofore. When the reducing ~ -agent used is sodium bis(2-methoxyethoxy)-aluminium hydride or sodium aluminium diethylhydride, the solvent is most usually benzene or toluene, which both may also be used in the present instance. However, it has unexpectedly been found that a better result is achieved if the reaction is carried out in dioxane that is, the reaction mixture used in the preparation of the imine derivative may be used as such. It is indicated to evaporate the excess amount of tert.-butylamine at reduced pressure, in order to save reducing agent. This simultaneous -hydrogenation and reduction of the imine derivative (V) is only possible provided that the phenolic hydroxyl group in the benzene ring is protected. If no protection has been applied, one has to extract the product from an aqueous solu-tion, considering the known solubility characteristics of ~1_ ' tert.-butylaminonethyl-4-hydroxy-m-xylene-~1, ~3-diole, thisis an impossible undertaking on an industrial scale, and in ; addition considerable amounts of undesired secondary products are formed.
The arylmethyl protective group in the compound (VIII) may be removed by catalytic hydration, for which ' palladium carbon, for instance, is a suitable catalyst and '~ 30 alcohol, for instance, is a suitable solvent.
The invention is illustrated with the ald of examples in the following.
.
- . - . ~. , ., ~ . , : : , Example 1 1040~58 -tert.-butylaminomethvl-4-benzyloxy-m-xylene-~1, a3-diole To 59 kg of dioxane, 0.35 kg water are added and the mixture is heated to 70-80C. Addition of 4.39 kg selenium dioxide. After the selenium dioxide has dissolved, 11.8 kg ethylester of 5-aceto-2-benzyloxybenzoic acid, dissolved in 35.5 kg dioxane, are added. The reaction mixture is further heated during this addition until the reaction mixture boils (appr. 100 C). Reflux boiling is continued for 6 hrs. During the boiling the colour bf the reaction mixture turns black, owing to the selenium precipitated.
After the boiling the mixture is allowed to cool to room temperature. The selenium is filtered off. (If it is desired --to isolate the glyoxal derivative, this is done by evaporating the dioxane, whereby the glyoxal derivative, prepared in this manner, is obtained as a viscous oil.) Addition to the filtrate at room temperature, of 5.9 kg tert.-butylamine and agitation for 4 hrs at room temperature. Evaporation of the excess of tert.-butylamine at reduced pressure.
The reaction mixture is poured, in a nitrogen atmosphere, into 40 kg of a 70% benzene solution of sodium bis(2-methoxyethoxy~aluminium hydride. The addition is made at about 60C. After the addition, reflux boiling for one hour. The complex compound of reducing agent and product is decomposed in normal manner with the aid of water and hydrochloric acid. The oily product layer is separated, ~ dissolved in chloroform, dried with sodium sulphate and treated ; with active carbon. Evaporation of the chloroform at reduced pressure. From the evaporation residue the product may be recrystallized from ethanol if necessary. Yield: 8.8-9~0 kg (65-70% of theoretical), melting point: appr.l35C.
:' :
., ,,,, , . . ,. ., . ~ : . .
,: ,. .:... : . ' ., .' , , :
Example 2 104~6S8 Start as in Example 1, but after preparation of the imine derivative the solvents are evaporated. By this procedure the imine derivative is obtained as a viscous oil, which is dissolved in 80 kg benzene. The benzene solution is poured, in a nitrogen atmosphere, into 40 kg of a 70% benzene solution of sodium bis(2-methoxyethoxy) aluminium hydride. Continue as in Example 1. Yield: 7.5-8.0 kg (58-62% of theoretical), melting point: appr. 135C. -Example 3 As Examples 1 and 2, but using instead of the ethyl ester of 5-aceto-2-benzyloxybenzoic acid, the equivalent amount of methylester. ~ ~
Example 4 ~ -To 66 kg of dioxane, 0.4 kg water are added and the mixture is heated to 70-80C. Addition of 4.92 kg selenium -~
dioxide. After the selenium dioxide has dissolved, addition of 13.2 kg ethylester of 5-aceto-2-benzyloxybenzoic acid, dissolved in 40 kg of dioxane. Heating continued until the '~ 20 reaction mixture boils (appr. 100C), followed by reflux boiling for 6 hrs. During the boiling the reaction mixture turns black - from the selenium precipitated. The reaction mixture is allowed to cool to room temperature and the precipitated selenium is filtered off. Addition to the filtrate at room temperature, of 6.6 kg tert.- butylamine and agitation at room temperature for 4 hrs. Evaporation of the excess of tert.-butylamine at reduced pressure.
; Dioxane solution at room temperature is added, in a nitrogen atmosphere, to 85.5 kg of 25% toluene solution of sodium aluminium diethyldihydride at a rate such that the temperature in the reaction mixture does not surpass 25C.
After this addition, continue agitating at 25C for one hour.
,, . : . . . , . . : ~ ,.
.: , : . . .
.
The complex compound o~ product and reducing agent thus formed is decomposed in normal manner by additing water and alkali solution. The additions have to be made slowly, owing to the effervescence caused by the liberated ethane.
The organic phase is separated and inspissated. From the evaporation residue the product may be recrystallized from ethanol if required. Yield: 9.5-10.3 kg (65-70% of theore-tical), melting point: appr. 135C.
Example 5 As Example 4, but after preparation of the imine derivative the solvents are evaporated. The imine derivative is then obtained as a viscous oil, which is dissol~ed in 90 kg of toluene, and this toluene solution is used in the continua-tion. Continue as in Example 4. Yield: 8.5-9.1 kg (58-62%
of theoretical), melting point: appr. 135C.
Example 6 As Examples 4 and 5, but instead of the ethylester of 5-aceto-2-benzyloxybenzoic acid, use the equivalent amount of methylester.
Example 7 a1-tert -butylaminomethyl-4-hydroxy-m-xylene-al, a3-diole 10 kg of al-tert. -butylaminomethyl-4-benzyloxy-~ m-xylene-al, a3 diole are added to 135 kg of 95% ethanol.
-' Addition of 0.3 kg palladium carbon and hydrogenation at normal pressure, until the hydrogen consumption ceases. After , removal of the catalyst, evaporate the solvents. From the , evaporation residue the product is crystallized with the aid of a methanol-ethanol mixture. Yield: 6.5 kg (90% of theoretical?, melting point: 157-158C.
Example 8 a1=tert.-butylaminomethyl-4-hvdroxY-m-xylene-al,~3-diol To 66 kg of dioxane, 0.4 kg water are added and the mixture is heated to 70-80C. 4.92 kg of selenium dioxide are ~ 7 ~
: , :
., ., . , ., .. . , ,, .
1~40658 added. On dissolution of the selenium dioxide, 13.2 kg of 5-aceto-2-benzyloxybenzoic acid ethyl ester, solved in 40 kg of dioxane, are added. Heating is continued until the reaction mixture boils (appr. 100C), followed by reflux boiling for six hours. During the boiling the reaction mixture turns black from precipitated selenium. The reaction mixture is ~ -allowed to cool to room temperature and the precipitated selenium is filtered off. Addition to the filtrate at room temperature of 6.6 kg tert. butylamine and agitation at room ~-temperature during four hours. The excess tert. butylamine -~
is evaporated at reduced pressure.
Dioxane solution at room temperature is added in a nitrogen atmosphere to 85.5 kg of a 25% toluene solution of sodium aIuminium diethyldihydride at a rate such that the temperature in the reaction mixture does not exceed 25C.
Following the addition, agitation is continued at 25C for one hour. The complex compound of product and reducing agent that has formed is decomposed in normal manner by adding water and alkali solution. The additions have to be made slowly owing to the effervescence caused by released ethane.
The organic phase is separated and insipissated. 135 kg of 95% ethanol are added to the inspissation residue. Further, addition of 0.3 kg of 10% palladium carbon and hydrogenation at normal pressure, until the hydrogen consumption ceases. On removal of the catalyst, the solvents are evaporated. The product is crystallized from the evaporation residue with the aid of a methanol/ethyl acetate mixture.
The yield is 6.2-6.7 kg (59-63% of theoretical), -melting point 157-158C.
Example 9 ~ ;
-tert.-butylaminomethy1-4-hydroxv-m-xylene-~1, ~3-diol To 59 kg of dioxane, 0,35 kg water are added and k ~ .
`' ... , . : : .
,: ~ , . . , ; :
lQ4~658 the mixture is heated to 70-80C. 4.39 kg of selenium dioxide are added. On dissolution of the selenium dioxide, 11.8 kg of 5-aceto-2-benzyloxybenzoic acid ethyl ester, solved in 35.5 kg of dioxane, are added. The reaction mixture is further heated during the addition until the reaction mixture boils (appr. 100C). Reflux boiling is continued for six hours.
I During the boiling the colour of the reaction mixture turns j black, owing to precipitated.
, .
A
,~ ' ' . . .
104al~S~
selenium. ~fter boiling, the mixture i9 allowed to cool to room temperature. The selenium is filtered off (If it is de 9i-red to isolate the glyoxal derivative, this is done by evapora-ting the dioxane, whereby the glyoxal derivative, prepared in this manner~ is obtained as a viscous oil.) To the filtrate at room temperature, 5.9 kg of tert.butyla-mine are added, with agitation at room temperature during four hours. Evaporation of the exce~s tert.butylamine at reduced pressure.
The reaction mixture is made to run, in a nitrogen atmosph~-re, into 40 kg of 70% benzene solution of sodium bis(2-methoxy) aluminiumhydride. The addition is made at appr. 60C. After ; this addition, reflu~ boiling for one hour. The complez com-pound which is formed between the reducing agent and the pro-i duct i9 decomposed in normal manner with the aid of water and hydrochloric acid. The oily product layer is separated, solved 1 in chloroform, set free from it~ hydrochloride salt with a basic I ~olution, dried with sodium sulphate and treated with active carbon. ~he chloroform is evaporated at reduced pressure. To the evaporation residue 120kg of 95% ethanol are added. Addi-tion of 0.26 kg of 10~ palladium carbon and hydrogenation at normal pressure, until the hydrogen consump-tion ceases. After , removal o~ the catalyst, the solvents are evaporated. ~he pro-. .
duct is crystallized from the evaporation residue with the aid of a methanol/ethyl aoetate mixture.
The yield is 5.5-5.9 kg (58-62% of theoretical), melting ~ -point 157-158C.
.
~; ~ . . - , .
.''i.................................................... . .
:, .
_ ~ _ :~
.~. . . . . ..
. .
. . ... . . , . . :: . . , :
Claims (2)
1. A method for preparing .alpha.1-tert.-butylaminomethyl-4-hydroxy-m-xylene-.alpha.1,.alpha.3-diole having the formula:
and its pharmaceutically acceptable acid addition salts, which comprises converting an imine derivative having the formula:
where R represents a lower straight-chain or branched hydrocarbon radical containing 1 to 6 carbon atoms, and Ar is an aryl group, into an intermediate compound having the formula:
by simultaneous hydrogenation and reduction in the presence of a catalyst selected from the group consisting of sodium bis-(2-methoxyethoxy) aluminum hydride and sodium aluminum diethyl dihydride, removing the arylmethyl protective group from the intermediate compound by catalytic hydrogenation and, where a pharmaceutically acceptable acid addition salt is required, reacting the resulting .alpha.1-tert.-butylaminomethyl-4-hydroxy-m-xylene-.alpha.1, .alpha.3-diole with a pharmaceutically acceptable organic or inorganic acid to provide the corresponding acid addition salt.
and its pharmaceutically acceptable acid addition salts, which comprises converting an imine derivative having the formula:
where R represents a lower straight-chain or branched hydrocarbon radical containing 1 to 6 carbon atoms, and Ar is an aryl group, into an intermediate compound having the formula:
by simultaneous hydrogenation and reduction in the presence of a catalyst selected from the group consisting of sodium bis-(2-methoxyethoxy) aluminum hydride and sodium aluminum diethyl dihydride, removing the arylmethyl protective group from the intermediate compound by catalytic hydrogenation and, where a pharmaceutically acceptable acid addition salt is required, reacting the resulting .alpha.1-tert.-butylaminomethyl-4-hydroxy-m-xylene-.alpha.1, .alpha.3-diole with a pharmaceutically acceptable organic or inorganic acid to provide the corresponding acid addition salt.
2. A method according to claim 1, wherein the simultaneous hydrogenation and reduction of the imine derivative is carried out in dioxane, benzene or toluene.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI982/74A FI56673C (en) | 1974-03-29 | 1974-03-29 | NYTT FOERFARANDE FOER FRAMSTAELLNING AV ALFA-TERT-BYTYLAMINOMETHYL-4-HYDROXY-M-XYLEN-ALFA1 ALFA3-DIOL |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1040658A true CA1040658A (en) | 1978-10-17 |
Family
ID=8504919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA223,245A Expired CA1040658A (en) | 1974-03-29 | 1975-03-27 | INDUSTRIAL METHOD FOR PRODUCING .alpha.1-TERT.-BUTYLAMINO-METHYL-4-HYDROXY-M-XYLENE-.alpha.1,.alpha.3-DIOLE |
Country Status (7)
Country | Link |
---|---|
JP (1) | JPS5953256B2 (en) |
CA (1) | CA1040658A (en) |
DK (1) | DK135500C (en) |
FI (1) | FI56673C (en) |
NO (1) | NO140297C (en) |
SE (1) | SE433608B (en) |
SU (1) | SU538660A3 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7465831B2 (en) | 2004-05-20 | 2008-12-16 | Teva Pharmaceutical Fine Chemicals S.R.L. | Levalbuterol hydrochloride Polymorph A |
CN110963929A (en) * | 2019-11-26 | 2020-04-07 | 安徽恒星制药有限公司 | Preparation method of salbutamol hydrochloride suitable for industrial production |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0043807B1 (en) | 1980-07-09 | 1984-05-30 | Aktiebolaget Draco | 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates |
FI118418B (en) | 2003-04-17 | 2007-11-15 | Ecocat Oy | Aluminum-rounded catalytic converter for cleaning of gas leaks |
-
1974
- 1974-03-29 FI FI982/74A patent/FI56673C/en active
- 1974-08-06 SU SU2051832A patent/SU538660A3/en active
- 1974-10-14 JP JP49118004A patent/JPS5953256B2/en not_active Expired
-
1975
- 1975-03-25 NO NO751034A patent/NO140297C/en unknown
- 1975-03-26 DK DK133975A patent/DK135500C/en not_active IP Right Cessation
- 1975-03-27 CA CA223,245A patent/CA1040658A/en not_active Expired
- 1975-03-27 SE SE7503657A patent/SE433608B/en not_active IP Right Cessation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7465831B2 (en) | 2004-05-20 | 2008-12-16 | Teva Pharmaceutical Fine Chemicals S.R.L. | Levalbuterol hydrochloride Polymorph A |
US7488758B2 (en) | 2004-05-20 | 2009-02-10 | Teva Pharmaceutical Fine Chemicals, S.R.L. | Levalbuterol hydrochloride polymorph B |
CN110963929A (en) * | 2019-11-26 | 2020-04-07 | 安徽恒星制药有限公司 | Preparation method of salbutamol hydrochloride suitable for industrial production |
CN110963929B (en) * | 2019-11-26 | 2022-10-21 | 安徽恒星制药有限公司 | Preparation method of salbutamol hydrochloride suitable for industrial production |
Also Published As
Publication number | Publication date |
---|---|
SU538660A3 (en) | 1976-12-05 |
FI98274A (en) | 1975-09-30 |
SE433608B (en) | 1984-06-04 |
DK135500B (en) | 1977-05-09 |
NO751034L (en) | 1975-09-30 |
NO140297B (en) | 1979-04-30 |
JPS5953256B2 (en) | 1984-12-24 |
JPS50130732A (en) | 1975-10-16 |
SE7503657L (en) | 1975-09-30 |
DK135500C (en) | 1977-10-24 |
NO140297C (en) | 1979-08-08 |
DK133975A (en) | 1975-09-30 |
FI56673B (en) | 1979-11-30 |
FI56673C (en) | 1981-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0391070A1 (en) | Process for the preparation of N-methyl-3-(p-trifluoro-methylphenoxy)-3-phenyl-propylamine and their salts | |
CA1040658A (en) | INDUSTRIAL METHOD FOR PRODUCING .alpha.1-TERT.-BUTYLAMINO-METHYL-4-HYDROXY-M-XYLENE-.alpha.1,.alpha.3-DIOLE | |
US4329497A (en) | Method for the production of 4-hydroxyphenylacetic acid | |
HU191346B (en) | Process for preparing isosorbide-mononitrate | |
EP0219082A2 (en) | Process for preparing halogen-magnesium alanate, and its use | |
US4158012A (en) | Steroid synthesis process using mixed anhydride | |
US3883525A (en) | Thermal rearrangement of 3-aryloxytriazine-5(4H)-ones | |
EP0089037B1 (en) | Process for preparing optically active (s)-2-acetyl-7-(2-hydroxy-3-isopropylaminopropoxy)benzofuran and salts thereof | |
US4700007A (en) | Process for preparing macrocyclic ketones | |
US2862034A (en) | X-dibenzyloxy-x-nitrostyrenes | |
US4237057A (en) | Synthesis of quinone pyrano-gamma-lactone antibiotics and antifungal agents | |
US5550267A (en) | Process for the synthesis of haloalkylferrocenes | |
US4723045A (en) | Processes for preparing cholesta-1,5,7-trien-3-ol | |
DE2552365C2 (en) | Process for the preparation of 2,3-dimethoxy-5-methyl-1,4-benzoquinones substituted in the 6-position | |
US3969467A (en) | 12-Anti and syn-(N-benzyl-N-alkylaminomethyl)-10,11-dihydro-5,10-methano-5H-dibenzo[a,d]cycloheptenes and the salts thereof | |
US3819694A (en) | 6-(2-(3-hydroxyalkyl)-3,5-disubstituted-phenyl)hexanoic acids and salts thereof | |
FI59395B (en) | FRAMSTAELLNING AV ALFA-6-DEOXI-5-HYDROXITETRACYKLIN | |
EP0155610B2 (en) | Process for the manufacture of 2-hydroxy-(9h)-carbazole | |
US3829498A (en) | Process for preparing 5-hydroxy-1-tetralone | |
EP0230499A1 (en) | Process for preparing macrocyclic ketones | |
Carstenn-Lichterfelde et al. | Correlation of the diterpenoids sideritol and jativatriol | |
CH474465A (en) | Process for the preparation of a dihydroxy-diketone | |
FI66590C (en) | PROCEDURE FOR FRAMSTATION OF AV 5'-ALKANOYLAMINO-2 '- (2-HYDROXI-3-ISOPROPYLAMINOPROPOXY) -ACETOFENONE | |
FI59390C (en) | ALFA1-TERT.-BUTYLAMINOMETHYL-4-BENZYLOXY-M-XYLENE-ALFA1, ALFA3-DIOL SOM AER MELLAN PRODUCTS VID FRAMSTAELLNING AV ALFA1-TERT.-BUTYLAMINOMETHYL-4-HYDROXI-M-KSYL | |
US4192805A (en) | Process of preparing amino ethanols |